Latest News and Press Releases
Want to stay updated on the latest news?
-
The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.
-
Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
-
Robbins LLP is investigating claims that Ultragenyx (RARE) misled investors about Phase III Orbit and Cosmic trials for setrusumab.
-
DARIEN, Ill., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Americans are preparing to “spring forward” on Sunday, March 8, despite evidence that seasonal time changes and living on daylight saving...
-
Robbins LLP is Investigating Allegations that Picard Medical, Inc. (PMI) was the Subject of a Fraudulent Stock Promotion Scheme
-
Robbins LLP is Investigating Allegations that Ardent Health, Inc. (ARDT) Misled Investors Regarding its Accounts Receivable
-
Robbins LLP is Investigating Allegations that Ardent Health, Inc. (ARDT) Misled Investors Regarding its Accounts Receivable
-
Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Molina Healthcare, Inc. (MOH) Mislead Investors Regarding its Business Prospects.
-
Robbins LLP is Investigating Allegations that Lantheus Holdings, Inc. (LNTH) Misled Investors About Pylarify's Competitive Position